Cargando…
The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
SIMPLE SUMMARY: The biopharmaceutical industry increasingly focuses on the development of new anticancer drugs for effective cancer therapy. Despite these efforts, the success rate is low, and thereby, greater efficacy and better safety properties are required. The high failure rate in drug discover...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105149/ https://www.ncbi.nlm.nih.gov/pubmed/35565273 http://dx.doi.org/10.3390/cancers14092144 |